December 06, 2017 article Open access A Pharmacometric Approach to Substitute for a Conventional Dose-Finding Study in Rare Diseases: Example of Phase III Dose Selection for Emicizumab in Hemophilia A Clinical Pharmacokinetics DOI: 10.1007/s40262-017-0616-3 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 2 stored of 81 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Pharmacokinetic-guided dose reduction of emicizumab in congenital hemophilia A: interim analysis of the DosEmi study 2025 Journal of Thrombosis and Haemostasis article Medicine Hemophilia Treatment and Research Open access 7 citations Virtual Patient Simulation Using Copula Modeling 2023 Clinical Pharmacology & Therapeutics article Mathematics Statistical Methods in Clinical Trials Open access 17 citations 2 results References 0